These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 20732299)
1. Learning from oncocytic tumors: Why choose inefficient mitochondria? Gasparre G; Romeo G; Rugolo M; Porcelli AM Biochim Biophys Acta; 2011 Jun; 1807(6):633-42. PubMed ID: 20732299 [TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration. Ferreira-da-Silva A; Valacca C; Rios E; Pópulo H; Soares P; Sobrinho-Simões M; Scorrano L; Máximo V; Campello S PLoS One; 2015; 10(3):e0122308. PubMed ID: 25822260 [TBL] [Abstract][Full Text] [Related]
3. Etiopathogenesis of oncocytomas. Correia M; Pinheiro P; Batista R; Soares P; Sobrinho-Simões M; Máximo V Semin Cancer Biol; 2017 Dec; 47():82-94. PubMed ID: 28687249 [TBL] [Abstract][Full Text] [Related]
4. Molecular features of thyroid oncocytic tumors. Gasparre G; Bonora E; Tallini G; Romeo G Mol Cell Endocrinol; 2010 May; 321(1):67-76. PubMed ID: 20184940 [TBL] [Abstract][Full Text] [Related]
5. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852 [TBL] [Abstract][Full Text] [Related]
6. Molecular and metabolic features of oncocytomas: Seeking the blueprints of indolent cancers. De Luise M; Girolimetti G; Okere B; Porcelli AM; Kurelac I; Gasparre G Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):591-601. PubMed ID: 28115060 [TBL] [Abstract][Full Text] [Related]
7. Oncocytic lesions of the thyroid, kidney, salivary glands, adrenal cortex, and parathyroid glands. Máximo V; Rios E; Sobrinho-Simões M Int J Surg Pathol; 2014 Feb; 22(1):33-6. PubMed ID: 24406625 [TBL] [Abstract][Full Text] [Related]
8. Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumors. Zimmermann FA; Mayr JA; Feichtinger R; Neureiter D; Lechner R; Koegler C; Ratschek M; Rusmir H; Sargsyan K; Sperl W; Kofler B Front Biosci (Elite Ed); 2011 Jan; 3(1):315-25. PubMed ID: 21196312 [TBL] [Abstract][Full Text] [Related]
9. Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Máximo V; Sobrinho-Simões M Virchows Arch; 2000 Aug; 437(2):107-15. PubMed ID: 10993269 [TBL] [Abstract][Full Text] [Related]
16. Causative role for defective expression of mitochondria-eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors. Mussazhanova Z; Shimamura M; Kurashige T; Ito M; Nakashima M; Nagayama Y Cancer Sci; 2020 Aug; 111(8):2814-2823. PubMed ID: 32458504 [TBL] [Abstract][Full Text] [Related]
17. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy. Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201 [TBL] [Abstract][Full Text] [Related]
18. Mitochondria: The metabolic switch of cellular oncogenic transformation. Tan YQ; Zhang X; Zhang S; Zhu T; Garg M; Lobie PE; Pandey V Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188534. PubMed ID: 33794332 [TBL] [Abstract][Full Text] [Related]
19. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations. Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783 [TBL] [Abstract][Full Text] [Related]
20. The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism. Rogalinska M Mini Rev Med Chem; 2016; 16(7):524-30. PubMed ID: 26471969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]